News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Tucker Sean
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/21/2023 |
4
| Tucker Sean (SVP, Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Granted 54,157 shares
@ $0
Granted 90,000 shares
@ $0
Granted 205,000 options to buy
@ $0.78, valued at
$159.9k
Granted 410,000 options to buy
@ $0.78, valued at
$319.8k
|
|
| 04/25/2022 |
4
| Tucker Sean (SVP, Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Exercised 40,000 options to buy
@ $0.77, valued at
$30.8k
|
|
| 03/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Exercised 4,026 options to buy
@ $6.49, valued at
$26.1k
|
|
| 06/09/2020 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 360,000 options to buy
@ $1.7, valued at
$612k
|
|
| 05/14/2019 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 124,061 options to buy
@ $0.77, valued at
$95.5k
|
|
| 04/12/2019 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Bought 27,273 shares
@ $1.1, valued at
$30k
Bought 27,273 warrants
@ $1.1, valued at
$30k
|
|
| 05/29/2018 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 14,000 options to buy
@ $5.17, valued at
$72.4k
|
|
| 03/14/2018 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Exercised 2,013 options to buy
@ $6.49, valued at
$13.1k
|
|
| 02/15/2018 |
4
| Tucker Sean (Chief Scientific Officer) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 3,020 options to buy
@ $8.03, valued at
$24.3k
Granted 10,523 options to buy
@ $6.49, valued at
$68.3k
Granted 11,604 options to buy
@ $8.03, valued at
$93.2k
Granted 10,067 options to buy
@ $17.49, valued at
$176.1k
Granted 7,731 options to buy
@ $12.98, valued at
$100.3k
Granted 9,060 options to buy
@ $4.07, valued at
$36.9k
Granted 45,640 shares
@ $0
Granted 9,060 shares
@ $0
Granted 25,388 shares
@ $0
Granted 2,014 options to buy
@ $6.49, valued at
$13.1k
Granted 4,027 options to buy
@ $6.49, valued at
$26.1k
|
|
| 02/14/2018 |
3
| Tucker Sean (Chief Scientific Officer) has filed a Form 3 on Aviragen Therapeutics, Inc. |
|
|